Clonality, Antigen Recognition, and Suppression of CD8(+) T Cells Differentially Affect Prognosis of Breast Cancer Subtypes

Dora Hammerl; MPG Massink; Marcel Smid; Carolien van Deurzen; HE Meijers-Heijboer; Q Waisfisz; Reno Debets; John Martens

doi:10.1158/1078-0432.Ccr-19-0285

Clonality, Antigen Recognition, and Suppression of CD8(+) T Cells Differentially Affect Prognosis of Breast Cancer Subtypes

Dora Hammerl, MPG Massink, Marcel Smid, Carolien van Deurzen, HE Meijers-Heijboer, Q Waisfisz, Reno Debets, John Martens

Research output: Contribution to journal › Article › Academic › peer-review

25 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	505-517
Number of pages	13
Journal	Clinical Cancer Research
Volume	26
Issue number	2
DOIs	https://doi.org/10.1158/1078-0432.Ccr-19-0285
Publication status	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1078-0432.Ccr-19-0285

Cite this

@article{2e05d4b6a9d841a6bf540691ef26493c,

title = "Clonality, Antigen Recognition, and Suppression of CD8(+) T Cells Differentially Affect Prognosis of Breast Cancer Subtypes",

author = "Dora Hammerl and MPG Massink and Marcel Smid and {van Deurzen}, Carolien and HE Meijers-Heijboer and Q Waisfisz and Reno Debets and John Martens",

year = "2020",

doi = "10.1158/1078-0432.Ccr-19-0285",

language = "Undefined/Unknown",

volume = "26",

pages = "505--517",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "2",

}

TY - JOUR

T1 - Clonality, Antigen Recognition, and Suppression of CD8(+) T Cells Differentially Affect Prognosis of Breast Cancer Subtypes

AU - Hammerl, Dora

AU - Massink, MPG

AU - Smid, Marcel

AU - van Deurzen, Carolien

AU - Meijers-Heijboer, HE

AU - Waisfisz, Q

AU - Debets, Reno

AU - Martens, John

PY - 2020

Y1 - 2020

U2 - 10.1158/1078-0432.Ccr-19-0285

DO - 10.1158/1078-0432.Ccr-19-0285

M3 - Article

SN - 1078-0432

VL - 26

SP - 505

EP - 517

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 2

ER -